期刊文献+

耐氟喹诺酮类药物鸡毒支原体DNA回旋酶及拓扑异构酶Ⅳ的突变特征 被引量:4

Characterization of Mutations in DNA Gyrase and Topoisomerase Ⅳ Involved in Quinolone Resistance of Clinical Mycoplasma gallisepticum Isolates
下载PDF
导出
摘要 采用二倍稀释法测定临床分离的4株鸡毒支原体对常用抗菌药物的敏感性,PCR方法和基因测序法对鸡毒支原体DNA回旋酶编码基因gyrA、gyrB及拓扑异构酶Ⅳ编码基因parC和parE耐药决定区进行分析。敏感性测定结果表明,4株分离鸡毒支原体对泰乐菌素、泰妙林、沃尼妙林和替米考星有很高的敏感性,对四环素和红霉素中度敏感,对林可霉素、氟苯尼考和氟喹诺酮类药物呈现不同程度的耐药性。4株耐氟喹诺酮类药物鸡毒支原体均在GyrA和ParC的喹诺酮类耐药决定区(QRDR)发生氨基酸的改变,GyrA的氨基酸取代模式有两种,分别为Ser81→Gly和Ser83→Ile,ParC仅在80位发生氨基酸取代(Ser80→Leu),GyrB和ParE均未发生氨基酸改变。 Susceptibilities of 4 isolated M.gallisepticum to common used antimicrobials were determined by broth dilution method.PCR and sequencing were applied for analysis of quinolone resistance-determining regions of the four target genes encoding DNA gyrase and topoisomerase Ⅳ from 4 isolates.The results showed that 4 isolates presented higher susceptible to tylosin,tiamulin,valnemulin and tilmicosin,moderate susceptible to tetracycline and erythromycin,and resistant to lincomycin,florfenicol and 3 fluroquinolone drugs to a certain extent.Several mutations were found in the two fluoroquinolone targets GyrA and ParC.Double mutations within QRDR of GyrA were found among 4 isolated M.gallisepticum,with the same substitution patterns of Ser81→Gly and Ser83→Ile.There was only one alteration existed within QRDR of ParC(Ser80→Leu) among 4 isolates.No mutations were found within QRDR of GyrB and ParE in 4 isolates.
出处 《中国畜牧兽医》 CAS 北大核心 2010年第9期43-47,共5页 China Animal Husbandry & Veterinary Medicine
基金 国家自然科学基金资助项目(30871890)
关键词 鸡毒支原体 最低抑菌浓度 DNA回旋酶 拓扑异构酶Ⅳ Mycoplasma gallisepticum minimum inhibitory concentration DNA gyrase topoisomerase Ⅳ
  • 相关文献

参考文献18

  • 1孔意端,林居纯,陈继荣,陈杖榴,曾振灵,蒋红霞.鸡毒支原体不同地区分离株对常用抗菌药物的敏感性试验[J].动物医学进展,2008,29(6):35-38. 被引量:15
  • 2刘利明,胡登峰,汪洋,冯立志.鸡毒支原体的研究进展[J].中国畜牧兽医,2005,32(6):60-62. 被引量:14
  • 3毕丁仁,王桂枝编著..动物霉形体及研究方法[M].北京:中国农业出版社,1998:171.
  • 4蒋红霞,陈杖榴,曾振灵,邓旭明,欧阳红生,梁焕春.氟喹诺酮类药物压力下鸡毒支原体gyrA基因突变特征分析[J].中国兽医杂志,2004,40(10):60-62. 被引量:4
  • 5Bebear C M,Charron A,Bove J M,et al.Cloning and nucleotide sequences of the topoisomerase Ⅳ parC and parE genes of Mycoplasma hominis[J].Antimicrobial Agents and Chemotherapy,1998,42:2024-2031. 被引量:1
  • 6Conrad S,Oethinger M,et al.GyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli[J].Journal of Antimicrobial Chemotherapy,1996,38(3):443-455. 被引量:1
  • 7Deborah J E,Luke R,et al.Prevalence of mutations within the quinolone resistance-determining region of gyrA,gyrB,parC,and pare and association with antibiotic resistance in quinolone-resistant Salmonella enterica[J].Antimicrobial Agents and Chemotherapy,2004,48(10):4012-4015. 被引量:1
  • 8Jorgensen J H,et al.Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA,parC,and pare loci[J].Antimicrobial Agents and Chemotherapy,1999,43(2):329-334. 被引量:1
  • 9Lindback E,Rahman M,Jalal S,et al.mutations in gyrA,gyrB,parC,and pare in quinolone-resistant strains of Neisseria gonorrhoeae[J].APMIS,2002,110(9):651-657. 被引量:1
  • 10Ouabdesselam S,David C,et al.Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations[J].Antimicrobial Agents and Chemotherapy,1995,39(8):1667-1670. 被引量:1

二级参考文献17

  • 1林居纯,曾振灵,向蓉,孔意端.鸡毒支原体的分离与鉴定[J].养禽与禽病防治,2007(8):21-22. 被引量:6
  • 2Reinhardt A K, Bebear C M, Kobisch M, et al. Characteriza-tion of mutations in DNA Gyrase and Topoisomerase IV involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro[J]. Antimicrob Agents and Chemother,2002,46(2):590-593. 被引量:1
  • 3Reinhardt A K, Kempf I, Kobisch, et al. Fluoroquinolone re-sistance in Mycoplasma gallisepticum: DNA gyrase as primary target of enrofloxacin and impact of mutations in topoisomerase on resistance level[J]. J Antimicrob Chemother, 2002, 50(4):589-592. 被引量:1
  • 4Levisohn S, Rosengarten, Yogev D. In vivo variation of Mycoplasrna gallisepticum antigen expression in experimentally injected chickens[J]. Vet Microbiol, 1995, 45:219-231. 被引量:1
  • 5Bradbury J M, Yavari C A, Giles C J. In vitro evaluation of various antimicrobials against Mycoplasma gallisepticurn and Mycoplasma synoviae by the micro-broth method and comparison with a commercially prepared test system [J]. Avian Pathol,1994, 23:105-115. 被引量:1
  • 6Cooper A C, Fuller J R, Fuller M K, et al. In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importance[J]. Res Vet Sei, 1993, 54:329-334. 被引量:1
  • 7Hannan P C T, Hanlon P J, Rogers N H. In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens[J]. Res Vet Sci,1989, 46:202-211. 被引量:1
  • 8Gautier-Bouchardon A V, Reinhardt A K, Kobich M, et al. In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae [J]. Vet Microbiol,2002,88(1) :47-58. 被引量:1
  • 9Jordan F T, Forrester C A, Ripley G H, et al. In vitro and in vivo comparisons of xalnemulin, tiamulin, tylosin, enrofloxacin, and lincomycin/spectinomycin against Mycoplasma gallisepticum [J]. Avian Disease, 2003, 37 : 475-482. 被引量:1
  • 10杨本升,刘玉斌,苟仕金,等.动物微生物学[M].吉林长春:吉林科学技术出版社,1995:738-742. 被引量:1

共引文献27

同被引文献52

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部